期刊文献+

食管小细胞癌的临床病理分析 被引量:11

Clinicopathologic Observation on Small Cell Carcinomaof the Esophagus
下载PDF
导出
摘要 目的:探讨食管小细胞癌的组织起源、生物学特性以及影响其预后的相关因素。方法:应用多种免疫组织化学检测的方法对63例食管小细胞癌进行了广谱细胞角蛋白(CK)、神经元特异性烯醇化酶(NSE)、嗜铬粒-A(CHr-A)、突触素(Syn)和CD56的检测。结果:63例食管小细胞癌,光镜下分为单一型小细胞癌(28/63)和混合型小细胞癌(35/63)。CK、NSE、CHr-A、Syn和CD56的阳性率分别为41.3%、36.5%、90.5%、60.3%和50.8%。5种抗体在单一型小细胞癌和混合型小细胞癌中的阳性表达情况比较(P>0.05),差别无显著性意义。影响预后的主要因素是肿瘤体积、浸润深度、残端(+)和瘤栓及淋巴结转移,与组织学类型及有无神经内分泌表达无关。结论:食管小细胞癌为高恶度肿瘤,对神经源性特异性抗体表达有明显的亲和性;其组织来源尚难定论,本研究倾向于非神经上皮源性。 Objective: To investigate the histogenesis and biological characteristics and factors influencing prognosis of the small cell carcinoma of the esophagus. Methods: Expression of five protein which consist of CK, NSE, CHr-A, Syn, and CD56 was examined immunohistochemically in 63 cases of the small cell carcinoma of the esophagus. Results: Sixty-three cases of the small cell carcinoma of the esophagus was divided into two types, ie pure small cell (28/63)and compound small cell (35/63). The result of immunohistochemistry showed: CK in 41.3%, NSE in 36.5%, Syn in 90.5%, CHr-A in 60.3% and CD56 in 50.8%. In statistics,the expression of five antibodies in pure small cell carcinoma and in compound small cell carcinoma is undistinguishable. The bulk of the tumor and the depthe of tumor invasion and the positive end to end of the tumor and lymphnode metastasis were the major determinants influencing long-term survial. Conclusion: Small cell carcinoma of the esophagus is a kind of high malignant tumors, which highly express neuroendocrine antigene. The histophathologic origin is still uncertain. But this study has been adoptive to the epicyted origin.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2004年第2期65-68,共4页 Chinese Journal of Clinical Oncology
基金 河北省科委基金资助(编号:99276141D)
关键词 食管小细胞癌 综合性免疫组化 上皮源性 预后 Small cell carcinoma of the esophagus Associated immunohistochemical Epicyted origin Prognosis
  • 相关文献

参考文献10

  • 1[1]Hatori S, Imada T, Rino Y, et al. Small cell carcinoma of the esophagus: a case report[J]. Hepatogastroenterology, 1999,46(27) :1788~1790
  • 2[2]Kimura H, Konishi K, Maeda K. Highy aggressive behavior and poor prognosis of small cell carcinoma in the alimentary tract: flow cytometric analysis and immunohistochemical staining for the P53 protein and proliferating cell nuclear antigen [J]. Dig Surg, 1999, 16(2): 152~157
  • 3[3]Bennoma J, Bardet E, Deguiral P, et al. Small cell carcinoma of the esophagus and review of the published data [J]. Am J Clin Oncol, 2000, 23(5):455~459
  • 4[4]Johnson PW, Joel SP, Love S, et al. Tumor markers for prediction of survival and monitoring of remission in small cell lung cancer[J]. BrJ Cancer, 1993, 67(4):760~766
  • 5[5]Fukunaga Y, Hirata S, Tanimura S, et al. Superficial undifferenti-ated small cell carcinoma of the esophagus showing an interesting granul in the histology [J]. Hepatogastroenter-ology,2000, 47(32): 429~432
  • 6[6]Ugras S, Akpolat N, Er M, et al. Primary composite tumour with bipart differentiation of the esophagus [J]. Acta Chir Brlg,2000, 100(1): 39~43
  • 7[7]Harmse JL, Carey FA, Baird AR, et al. Merkel cells in the human esophagus[J]. J Pathol, 1999,189(2):176~179
  • 8[8]Kaiyo K, Takubo K, Nakamura K, et al. Primary undifferentiated small cell carcinoma of the esophagus [J]. Hum Pathol,1999, 30(2): 216~221
  • 9[9]Nishimaki T, Suzuki T, Nakagawa S, et al. Tumour spread and outcome of treatment in primary esophageal small cell carcinoma[J]. J Surg Oncol, 1997, 64(2): 130~134
  • 10[10]Medgyesy CD, Wolff RA, Putnam JB Jr, et al. Small cell carcinoma of the esophagus: the University of Texas M.D.Anderson Cancer experienie and literature review [J]. Cancer,2000, 88(2):262~267

同被引文献81

引证文献11

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部